WeHand-Bio

Beijing, China · Founded 2010 · In IPO Registration

Developer and manufacturer of first-in-class natural drug innovations and advanced drug delivery systems designed for the treatment of complex metabolic disorders, malignant tumors, and… WeHand-Bio is based in Beijing, China and was founded in 2010. Its last reported valuation was $567 million in Sep 2025. It has raised $162 million.

Last reported valuation

$566.6M

Oct 2026

Priced at

—

Total raised

$162.0M

Last round

—

How much has WeHand-Bio raised?

$162.0Macross 0 recorded rounds

Free account

More of WeHand-Bio with a free account

·Watch WeHand-Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

WeHand-Bio investors

10 investors are on record for WeHand-Bio, including Cowin Capital, Shun Xi Fund, Lapam Capital and Zero2IPO Venture Capital.

For fundraisers

Raising for a company like WeHand-Bio?

10 investors have backed WeHand-Bio.

See all 10 investors →

Frequently asked about WeHand-Bio

How much has WeHand-Bio raised?: WeHand-Bio has raised $162.0M in total across 0 recorded funding rounds.